Amgen's MariTide phase 2 trial - 20% weight loss, no plateau, once a month injection

[clayd]

Pretty good results for MariTide

https://www.prnewswire.com/news-rel...at-52-weeks-in-a-phase-2-study-302316464.html

 

[clayd]

Apparently the market thinks 20% is weak sauce, shares getting killed

 

[rogertheveggie]

Apparently the market thinks 20% is weak sauce, shares getting killed

Buying opportunity? Looks like it’s around the 1Y lows…

 

[Lullabytreehugger]

Once a month dosing seems amazing!

 

[keangkong]

Apparently the market thinks 20% is weak sauce, shares getting killed

20% is quite good. While it's about the same as for tirzepatide, if they offer it for 10-50% less than Zepbound and offer once per month dosing, there is a lot of money to be made. With that said, while I invest in the stock market, I never pick winners and only invest in S & P 500 index funds or bonds; I never try to pick winners. I follow the advice of Jack Bogle: If you want to find a needle in a haystack, buy the haystack.

 

[keangkong]

Once a month dosing seems amazing!

It would be no big deal for me but I don't mind injecting myself. I'm sure it's a big deal for many folks.

 

[penewbie]

They had some pretty alarming bone loss news recently, I wouldn't get too excited.

 

[keangkong]

They had some pretty alarming bone loss news recently, I wouldn't get too excited.

One won't have to lose fat or muscle in order to lose weight. Maybe keeping the fat will enable the drug to avoid causing the GLP-1 chills from which I now suffer. Bones are overrated: Many invertebrates manage to do just fine without them.